These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30317548)

  • 1. Vitamin D supplementation and neurofilament light chain in multiple sclerosis.
    Holmøy T; Røsjø E; Zetterberg H; Blennow K; Lindstrøm JC; Steffensen LH; Kampman MT
    Acta Neurol Scand; 2019 Feb; 139(2):172-176. PubMed ID: 30317548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D
    Smolders J; Mimpen M; Oechtering J; Damoiseaux J; van den Ouweland J; Hupperts R; Kuhle J
    Acta Neurol Scand; 2020 Jan; 141(1):77-80. PubMed ID: 31657006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
    Røsjø E; Steffensen LH; Jørgensen L; Lindstrøm JC; Šaltytė Benth J; Michelsen AE; Aukrust P; Ueland T; Kampman MT; Torkildsen Ø; Holmøy T
    J Neurol; 2015 Dec; 262(12):2713-21. PubMed ID: 26429571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high-dose vitamin D
    Røsjø E; Lossius A; Abdelmagid N; Lindstrøm JC; Kampman MT; Jørgensen L; Sundström P; Olsson T; Steffensen LH; Torkildsen Ø; Holmøy T
    Mult Scler; 2017 Mar; 23(3):395-402. PubMed ID: 27325604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of daily high-dose vitamin D
    Hupperts R; Smolders J; Vieth R; Holmøy T; Marhardt K; Schluep M; Killestein J; Barkhof F; Beelke M; Grimaldi LME;
    Neurology; 2019 Nov; 93(20):e1906-e1916. PubMed ID: 31594857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.
    Holmøy T; Lindstrøm JC; Eriksen EF; Steffensen LH; Kampman MT
    BMC Neurol; 2017 Apr; 17(1):67. PubMed ID: 28376767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
    Smolders J; Hupperts R; Barkhof F; Grimaldi LM; Holmoy T; Killestein J; Rieckmann P; Schluep M; Vieth R; Hostalek U; Ghazi-Visser L; Beelke M;
    J Neurol Sci; 2011 Dec; 311(1-2):44-9. PubMed ID: 21620416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis.
    Golan D; Staun-Ram E; Glass-Marmor L; Lavi I; Rozenberg O; Dishon S; Barak M; Ish-Shalom S; Miller A
    Brain Behav Immun; 2013 Aug; 32():180-5. PubMed ID: 23665342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
    Bhargava P; Cassard S; Steele SU; Azevedo C; Pelletier D; Sugar EA; Waubant E; Mowry EM
    Contemp Clin Trials; 2014 Nov; 39(2):288-93. PubMed ID: 25311447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
    Laursen JH; Søndergaard HB; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2016 Nov; 10():169-173. PubMed ID: 27919484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis.
    Røsjø E; Lindstrøm JC; Holmøy T; Myhr KM; Varhaug KN; Torkildsen Ø
    Front Neurol; 2020; 11():329. PubMed ID: 32425877
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients.
    Hänninen K; Jääskeläinen O; Herukka SK; Soilu-Hänninen M
    Brain Behav; 2020 Sep; 10(9):e01772. PubMed ID: 32705821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose Vitamin D intake and quality of life in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.
    Ashtari F; Toghianifar N; Zarkesh-Esfahani SH; Mansourian M
    Neurol Res; 2016 Oct; 38(10):888-92. PubMed ID: 27597724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune regulatory effects of high dose vitamin D
    Muris AH; Smolders J; Rolf L; Thewissen M; Hupperts R; Damoiseaux J;
    J Neuroimmunol; 2016 Nov; 300():47-56. PubMed ID: 27806875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.
    Ashtari F; Toghianifar N; Zarkesh-Esfahani SH; Mansourian M
    Neuroimmunomodulation; 2015; 22(6):400-4. PubMed ID: 26401986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.
    de Flon P; Laurell K; Sundström P; Blennow K; Söderström L; Zetterberg H; Gunnarsson M; Svenningsson A
    Acta Neurol Scand; 2019 May; 139(5):462-468. PubMed ID: 30740668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
    Stein MS; Liu Y; Gray OM; Baker JE; Kolbe SC; Ditchfield MR; Egan GF; Mitchell PJ; Harrison LC; Butzkueven H; Kilpatrick TJ
    Neurology; 2011 Oct; 77(17):1611-8. PubMed ID: 22025459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
    Kuhle J; Disanto G; Lorscheider J; Stites T; Chen Y; Dahlke F; Francis G; Shrinivasan A; Radue EW; Giovannoni G; Kappos L
    Neurology; 2015 Apr; 84(16):1639-43. PubMed ID: 25809304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
    Mimpen M; Rolf L; Poelmans G; van den Ouweland J; Hupperts R; Damoiseaux J; Smolders J
    PLoS One; 2021; 16(12):e0261097. PubMed ID: 34855907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.